Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

In vivo profile of the anticoagulant effect of 17ß-amino-1,3,5(10)estratrien-3-ol.

Lemini C, Rubio-Póo C, Franco Y, Jaimez R, Avila ME, Medina M, Lemus AE.

Eur J Pharmacol. 2013 Jan 30;700(1-3):210-6. doi: 10.1016/j.ejphar.2012.12.030. Epub 2013 Jan 7.

PMID:
23305838
2.

Changes on hemostatic parameters induced by 17beta-estradiol, ethinylestradiol, and the 17beta-aminoestrogen pentolame in the male Wistar rat.

García-Manzano A, González-Llaven J, Jaimez R, Franco Y, Estela Avila M, Rubio-Póo C, Lemini C.

Steroids. 2002 Dec;67(13-14):1129-35.

PMID:
12441199
3.

Contrasting effects of estradiol and 17 beta-aminoestrogens on blood clotting time in rats and mice.

Lemini C, Franco Y, Avila ME, Jaimez R.

Eur J Pharmacol. 2005 Mar 14;510(3):229-33.

PMID:
15763247
4.

Anticoagulant and estrogenic effects of two new 17 beta-aminoestrogens, butolame [17 beta-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol].

Lemini C, Rubio-Póo C, Silva G, García-Mondragón J, Zavala E, Mendoza-Patiño N, Castro D, Cruz-Almanza R, Mandoki JJ.

Steroids. 1993 Oct;58(10):457-61.

PMID:
8256254
5.
6.

Effects on blood clotting time of 17 beta-estradiol and 17 beta-aminoestrogens in rats and mice.

Jaimez R, Rubio-Póo C, Lemini C.

Proc West Pharmacol Soc. 2001;44:163-6. No abstract available.

PMID:
11793970
7.

Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.

Gaussem P, Dubar M, le Bonniec B, Richard-Lordereau I, Jochemsen R, Aiach M.

Br J Clin Pharmacol. 2002 Feb;53(2):147-54.

8.

NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).

National Toxicology Program .

Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.

9.

Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats.

Lemini C, Jaimez R, Medina-Jiménez M, Ávila ME.

Indian J Pharmacol. 2012 Nov-Dec;44(6):749-53. doi: 10.4103/0253-7613.103287.

10.

In vivo estrogen bioactivities and in vitro estrogen receptor binding and transcriptional activities of anticoagulant synthetic 17beta-aminoestrogens.

Jaimez R, Cooney A, Jackson K, Lemus AE, Lemini C, Cárdenas M, García R, Silva G, Larrea F.

J Steroid Biochem Mol Biol. 2000 May;73(1-2):59-66.

PMID:
10822025
11.

Anticoagulant activity of original synthetic peptide derivatives.

Drozd NN, Tolstenkov AS, Makarov VA, Miphtakhova NT, Voyushina TL, Sergeev ME.

Bull Exp Biol Med. 2008 Jan;145(1):51-4.

PMID:
19024001
12.
13.

Pharmacokinetics and anticoagulant effect of the direct thrombin inhibitor melagatran following subcutaneous administration to healthy young men.

Johansson S, Wåhlander K, Larson G, Ohlsson L, Larsson M, Eriksson UG.

Blood Coagul Fibrinolysis. 2003 Oct;14(7):677-84.

PMID:
14517494
14.

SSR182289A, a novel, orally active thrombin inhibitor: in vitro profile and ex vivo anticoagulant activity.

Berry CN, Lassalle G, Lunven C, Altenburger JM, Guilbert F, Lalé A, Hérault JP, Lecoffre C, Pfersdorff C, Herbert JM, O'Connor SE.

J Pharmacol Exp Ther. 2002 Dec;303(3):1189-98.

15.
16.

Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex.

Sheehan JP, Lan HC.

Blood. 1998 Sep 1;92(5):1617-25.

17.

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.

van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A.

Thromb Haemost. 2010 Jun;103(6):1116-27. doi: 10.1160/TH09-11-0758. Epub 2010 Mar 29. Review.

PMID:
20352166
18.

In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.

Parsi K, Exner T, Connor DE, Ma DD, Joseph JE.

Eur J Vasc Endovasc Surg. 2007 Dec;34(6):731-40. Epub 2007 Oct 4.

19.

The dose-dependent effect of BHT (butylated hydroxytoluene) on vitamin K-dependent blood coagulation in rats.

Cottrell S, Andrews CM, Clayton D, Powell CJ.

Food Chem Toxicol. 1994 Jul;32(7):589-94.

PMID:
8045471
20.

The anticoagulant effect of hexolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect.

Rubio-Póo C, Lemini C, García-Mondragón J, de la Peña A, Jayme V, Mendoza-Patiño N, Zavala E, Silva G, Blickenstaff RT, Fernández JM, et al.

Steroids. 1990 Feb;55(2):83-6.

PMID:
2326832

Supplemental Content

Support Center